Numida meleagris isolate 19003 breed g44 Domestic line chromosome 23, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007836.1.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
phospholipid transfer protein C2CD2L isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
phospholipid transfer protein C2CD2L isoform X5
phospholipid transfer protein C2CD2L isoform X4
phospholipid transfer protein C2CD2L isoform X2
phospholipid transfer protein C2CD2L isoform X1
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase isoform X1
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
hydroxymethylbilane synthase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
hydroxymethylbilane synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
hydroxymethylbilane synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
VPS11, CORVET/HOPS core subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
VPS11, CORVET/HOPS core subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
VPS11, CORVET/HOPS core subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
VPS11, CORVET/HOPS core subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
vacuolar protein sorting-associated protein 11 homolog
salt inducible kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
salt inducible kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
serine/threonine-protein kinase SIK2 isoform X1
serine/threonine-protein kinase SIK2 isoform X2
salt inducible kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase SIK2 isoform X3
uncharacterized LOC110387586, transcript variant X2
uncharacterized LOC110387586, transcript variant X1
fasciculation and elongation protein zeta 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
fasciculation and elongation protein zeta-1
PBX/knotted 1 homeobox 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
PBX/knotted 1 homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
PBX/knotted 1 homeobox 2, transcript variant X1
PBX/knotted 1 homeobox 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
glucose-6-phosphate exchanger SLC37A2 isoform X1
glucose-6-phosphate exchanger SLC37A2 isoform X2
solute carrier family 37 member 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 37 member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
glucose-6-phosphate exchanger SLC37A2 isoform X4
glucose-6-phosphate exchanger SLC37A2 isoform X5
glucose-6-phosphate exchanger SLC37A2 isoform X3
coiled-coil domain containing 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
coiled-coil domain containing 15, transcript variant X3
coiled-coil domain containing 15, transcript variant X1
coiled-coil domain containing 15, transcript variant X5
coiled-coil domain containing 15, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
coiled-coil domain containing 15, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
coiled-coil domain-containing protein 15 isoform X2
coiled-coil domain-containing protein 15 isoform X1
coiled-coil domain-containing protein 15 isoform X3
coiled-coil domain-containing protein 15 isoform X4
coiled-coil domain-containing protein 15 isoform X5
hepatic and glial cell adhesion molecule, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
hepatic and glial cell adhesion molecule, transcript variant X1
hepatocyte cell adhesion molecule isoform X2
hepatocyte cell adhesion molecule isoform X1
roundabout guidance receptor 4, transcript variant X1
roundabout guidance receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
roundabout guidance receptor 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
roundabout guidance receptor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
roundabout guidance receptor 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
roundabout guidance receptor 3, transcript variant X5
roundabout guidance receptor 3, transcript variant X8
roundabout guidance receptor 3, transcript variant X4
roundabout guidance receptor 3, transcript variant X6
roundabout guidance receptor 3, transcript variant X1
roundabout guidance receptor 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
roundabout guidance receptor 3, transcript variant X14
roundabout guidance receptor 3, transcript variant X11
roundabout guidance receptor 3, transcript variant X13
roundabout guidance receptor 3, transcript variant X10
roundabout guidance receptor 3, transcript variant X12
roundabout guidance receptor 3, transcript variant X7
Myb/SANT DNA binding domain containing 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X13
Myb/SANT DNA binding domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
myb/SANT-like DNA-binding domain-containing protein 2 isoform X1
myb/SANT-like DNA-binding domain-containing protein 2 isoform X2
myb/SANT-like DNA-binding domain-containing protein 2 isoform X3
myb/SANT-like DNA-binding domain-containing protein 2 isoform X5
Myb/SANT DNA binding domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X7
Myb/SANT DNA binding domain containing 2, transcript variant X4
Myb/SANT DNA binding domain containing 2, transcript variant X8
Myb/SANT DNA binding domain containing 2, transcript variant X9
Myb/SANT DNA binding domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
myb/SANT-like DNA-binding domain-containing protein 2 isoform X4
endothelial cell-selective adhesion molecule
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
RNA pseudouridylate synthase domain containing 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RNA pseudouridylate synthase domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
RNA pseudouridylate synthase domain containing 4, transcript variant X5
RNA pseudouridylate synthase domain containing 4, transcript variant X3
RNA pseudouridylate synthase domain containing 4, transcript variant X1
RNA pseudouridylate synthase domain-containing protein 4 isoform X2
RNA pseudouridylate synthase domain-containing protein 4 isoform X3
RNA pseudouridylate synthase domain-containing protein 4 isoform X1
HYLS1, centriolar and ciliogenesis associated, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
HYLS1, centriolar and ciliogenesis associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
HYLS1, centriolar and ciliogenesis associated, transcript variant X4
HYLS1, centriolar and ciliogenesis associated, transcript variant X2
pseudouridylate synthase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
pseudouridylate synthase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
pseudouridylate synthase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
pseudouridylate synthase 3, transcript variant X3
HYLS1, centriolar and ciliogenesis associated, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
V-set and immunoglobulin domain containing 10 like 2, transcript variant X1
V-set and immunoglobulin domain containing 10 like 2, transcript variant X2
receptor-type tyrosine-protein phosphatase F
cell adhesion associated, oncogene regulated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X5
cell adhesion associated, oncogene regulated, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cell adhesion molecule-related/down-regulated by oncogenes isoform X1
cell adhesion molecule-related/down-regulated by oncogenes isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
STT3A, catalytic subunit of the oligosaccharyltransferase complex, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
STT3A, catalytic subunit of the oligosaccharyltransferase complex, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
STT3A, catalytic subunit of the oligosaccharyltransferase complex, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A
EI24, autophagy associated transmembrane protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
EI24, autophagy associated transmembrane protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
FAD dependent oxidoreductase domain containing 1, transcript variant X2
FAD dependent oxidoreductase domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
FAD-dependent oxidoreductase domain-containing protein 1 isoform X1
FAD-dependent oxidoreductase domain-containing protein 1 isoform X2
SRP receptor alpha subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
signal recognition particle receptor subunit alpha isoform X1
SRP receptor alpha subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
signal recognition particle receptor subunit alpha isoform X2
family with sequence similarity 118 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
family with sequence similarity 118 member B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
family with sequence similarity 118 member B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
family with sequence similarity 118 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X14
TIR domain containing adaptor protein, transcript variant X11
TIR domain containing adaptor protein, transcript variant X8
TIR domain containing adaptor protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X16
TIR domain containing adaptor protein, transcript variant X20
TIR domain containing adaptor protein, transcript variant X13
TIR domain containing adaptor protein, transcript variant X19
TIR domain containing adaptor protein, transcript variant X24
TIR domain containing adaptor protein, transcript variant X3
TIR domain containing adaptor protein, transcript variant X1
TIR domain containing adaptor protein, transcript variant X5
TIR domain containing adaptor protein, transcript variant X26
TIR domain containing adaptor protein, transcript variant X27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X28
TIR domain containing adaptor protein, transcript variant X12
TIR domain containing adaptor protein, transcript variant X4
TIR domain containing adaptor protein, transcript variant X18
TIR domain containing adaptor protein, transcript variant X22
TIR domain containing adaptor protein, transcript variant X23
TIR domain containing adaptor protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TIR domain containing adaptor protein, transcript variant X15
TIR domain containing adaptor protein, transcript variant X25
toll/interleukin-1 receptor domain-containing adapter protein isoform X3
toll/interleukin-1 receptor domain-containing adapter protein isoform X1
toll/interleukin-1 receptor domain-containing adapter protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X3
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X1
kin of IRRE like 3 (Drosophila), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kin of IRRE like 3 (Drosophila), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kin of IRRE like 3 (Drosophila), transcript variant X1
uncharacterized LOC110387775, transcript variant X2
uncharacterized LOC110387775, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC110387753, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110387753, transcript variant X1
uncharacterized LOC110387769, transcript variant X2
uncharacterized LOC110387769, transcript variant X3
uncharacterized LOC110387769, transcript variant X1
ETS proto-oncogene 1, transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ETS proto-oncogene 1, transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ETS proto-oncogene 1, transcription factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ETS proto-oncogene 1, transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ETS proto-oncogene 1, transcription factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ETS proto-oncogene 1, transcription factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Friend leukemia integration 1 transcription factor isoform X1
Friend leukemia integration 1 transcription factor isoform X3
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Friend leukemia integration 1 transcription factor isoform X2
Friend leukemia integration 1 transcription factor isoform X4
potassium voltage-gated channel subfamily J member 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily J member 5, transcript variant X6
potassium voltage-gated channel subfamily J member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily J member 5, transcript variant X4
potassium voltage-gated channel subfamily J member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily J member 5, transcript variant X8
potassium voltage-gated channel subfamily J member 5, transcript variant X2
potassium voltage-gated channel subfamily J member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ATP-sensitive inward rectifier potassium channel 1
G protein-activated inward rectifier potassium channel 4 isoform X3
G protein-activated inward rectifier potassium channel 4 isoform X4
G protein-activated inward rectifier potassium channel 4 isoform X1
potassium voltage-gated channel subfamily J member 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
G protein-activated inward rectifier potassium channel 4 isoform X2
Rho GTPase activating protein 32, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X6
Rho GTPase activating protein 32, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X2
Rho GTPase activating protein 32, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X12
Rho GTPase activating protein 32, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
rho GTPase-activating protein 32 isoform X3
rho GTPase-activating protein 32 isoform X1
rho GTPase-activating protein 32 isoform X2
rho GTPase-activating protein 32 isoform X4
uncharacterized LOC110387760, transcript variant X2
uncharacterized LOC110387760, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 45B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
transmembrane protein 45B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X6
transmembrane protein 45B-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 45B-like isoform X1
transmembrane protein 45B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 45B-like isoform X2
transmembrane protein 45B-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transmembrane protein 45B-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
amyloid beta precursor like protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
amyloid beta precursor like protein 2, transcript variant X2
amyloid beta precursor like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
amyloid beta precursor like protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
amyloid beta precursor like protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
amyloid beta precursor like protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
PR/SET domain 10, transcript variant X10
PR/SET domain 10, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
PR domain zinc finger protein 10 isoform X4
PR domain zinc finger protein 10 isoform X5
PR domain zinc finger protein 10 isoform X1
PR domain zinc finger protein 10 isoform X3
PR domain zinc finger protein 10 isoform X2
nuclear factor related to kappaB binding protein, transcript variant X1
nuclear factor related to kappaB binding protein, transcript variant X3
nuclear factor related to kappaB binding protein, transcript variant X2
nuclear factor related to kappaB binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
nuclear factor related to kappa-B-binding protein isoform X1
nuclear factor related to kappa-B-binding protein isoform X3
nuclear factor related to kappa-B-binding protein isoform X2
uncharacterized LOC110387744, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC110387744, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
suppression of tumorigenicity 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
suppression of tumorigenicity 14, transcript variant X3
suppression of tumorigenicity 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
suppression of tumorigenicity 14, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
suppression of tumorigenicity 14, transcript variant X8
suppression of tumorigenicity 14, transcript variant X9
suppression of tumorigenicity 14, transcript variant X4
suppression of tumorigenicity 14, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
suppressor of tumorigenicity 14 protein isoform X1
suppressor of tumorigenicity 14 protein isoform X2
suppression of tumorigenicity 14, transcript variant X6
suppressor of tumorigenicity 14 protein isoform X3
suppression of tumorigenicity 14, transcript variant X12
suppression of tumorigenicity 14, transcript variant X13
suppression of tumorigenicity 14, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
suppressor of tumorigenicity 14 protein isoform X4
suppression of tumorigenicity 14, transcript variant X11
suppressor of tumorigenicity 14 protein isoform X5
uncharacterized LOC110387745, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X22
uncharacterized LOC110387745, transcript variant X20
uncharacterized LOC110387745, transcript variant X16
uncharacterized LOC110387745, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X6
uncharacterized LOC110387745, transcript variant X13
uncharacterized LOC110387745, transcript variant X10
uncharacterized LOC110387745, transcript variant X8
uncharacterized LOC110387745, transcript variant X23
uncharacterized LOC110387745, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X21
uncharacterized LOC110387745, transcript variant X18
uncharacterized LOC110387745, transcript variant X17
uncharacterized LOC110387745, transcript variant X15
uncharacterized LOC110387745, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC110387745, transcript variant X14
uncharacterized LOC110387745, transcript variant X1
uncharacterized LOC110387745, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X7
zinc finger and BTB domain containing 44, transcript variant X15
zinc finger and BTB domain containing 44, transcript variant X10
zinc finger and BTB domain containing 44, transcript variant X12
zinc finger and BTB domain containing 44, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X16
zinc finger and BTB domain containing 44, transcript variant X18
zinc finger and BTB domain containing 44, transcript variant X13
zinc finger and BTB domain containing 44, transcript variant X8
zinc finger and BTB domain containing 44, transcript variant X9
zinc finger and BTB domain containing 44, transcript variant X11
zinc finger and BTB domain containing 44, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 44 isoform X8
zinc finger and BTB domain-containing protein 44 isoform X6
zinc finger and BTB domain containing 44, transcript variant X17
zinc finger and BTB domain-containing protein 44 isoform X5
zinc finger and BTB domain-containing protein 44 isoform X7
zinc finger and BTB domain containing 44, transcript variant X20
zinc finger and BTB domain-containing protein 44 isoform X10
zinc finger and BTB domain containing 44, transcript variant X19
zinc finger and BTB domain containing 44, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 44 isoform X4
zinc finger and BTB domain-containing protein 44 isoform X9
zinc finger and BTB domain containing 44, transcript variant X4
zinc finger and BTB domain containing 44, transcript variant X3
zinc finger and BTB domain containing 44, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 44 isoform X3
zinc finger and BTB domain-containing protein 44 isoform X2
zinc finger and BTB domain-containing protein 44 isoform X1
zinc finger and BTB domain containing 44, transcript variant X21
zinc finger and BTB domain-containing protein 44 isoform X11
ADAM metallopeptidase with thrombospondin type 1 motif 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 8
ADAM metallopeptidase with thrombospondin type 1 motif 15
A disintegrin and metalloproteinase with thrombospondin motifs 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
opioid binding protein/cell adhesion molecule like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
opioid binding protein/cell adhesion molecule like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
opioid-binding protein/cell adhesion molecule isoform X2
opioid-binding protein/cell adhesion molecule isoform X1
uncharacterized LOC110387653, transcript variant X1
uncharacterized LOC110387653, transcript variant X2
uncharacterized LOC110387791, transcript variant X3
uncharacterized LOC110387791, transcript variant X2
uncharacterized LOC110387791, transcript variant X1
uncharacterized protein LOC110387791 isoform X3
uncharacterized protein LOC110387791 isoform X1
uncharacterized protein LOC110387791 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GBYG01013688.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 42 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 21 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
non-SMC condensin II complex subunit D3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
non-SMC condensin II complex subunit D3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
non-SMC condensin II complex subunit D3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
condensin-2 complex subunit D3 isoform X2
condensin-2 complex subunit D3 isoform X1
condensin-2 complex subunit D3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26B
thymocyte nuclear protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
thymocyte nuclear protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
isobutyryl-CoA dehydrogenase, mitochondrial
beta-1,3-glucuronyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X2
beta-1,3-glucuronyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X3
beta-1,3-glucuronyltransferase 1, transcript variant X5
beta-1,3-glucuronyltransferase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC110387648, transcript variant X2
uncharacterized LOC110387648, transcript variant X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X5
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X3
uncharacterized LOC110387754, transcript variant X2
uncharacterized LOC110387754, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 42-like
ATPase H+/K+ transporting non-gastric alpha2 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
potassium-transporting ATPase alpha chain 2
sodium voltage-gated channel beta subunit 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium channel subunit beta-3
GRAM domain containing 1B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X1
GRAM domain containing 1B, transcript variant X3
GRAM domain containing 1B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X9
GRAM domain containing 1B, transcript variant X6
GRAM domain containing 1B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X10
GRAM domain containing 1B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
GRAM domain-containing protein 1B isoform X5
GRAM domain-containing protein 1B isoform X2
GRAM domain-containing protein 1B isoform X3
GRAM domain-containing protein 1B isoform X4
GRAM domain-containing protein 1B isoform X1
GRAM domain-containing protein 1B isoform X6
GRAM domain-containing protein 1B isoform X7
GRAM domain-containing protein 1B isoform X9
GRAM domain-containing protein 1B isoform X8
CXADR like membrane protein, transcript variant X3
CXADR like membrane protein, transcript variant X2
CXADR like membrane protein, transcript variant X4
CXADR like membrane protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CXADR like membrane protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
heat shock protein family A (Hsp70) member 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
chromosome 23 C11orf63 homolog, transcript variant X4
chromosome 23 C11orf63 homolog, transcript variant X3
chromosome 23 C11orf63 homolog, transcript variant X5
chromosome 23 C11orf63 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chromosome 23 C11orf63 homolog, transcript variant X1
uncharacterized protein C11orf63 homolog isoform X4
uncharacterized protein C11orf63 homolog isoform X2
uncharacterized protein C11orf63 homolog isoform X1
uncharacterized protein C11orf63 homolog isoform X3
chromosome 23 C11orf63 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
chromosome 23 C11orf63 homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 23 C11orf63 homolog, transcript variant X8
uncharacterized LOC110387560, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC110387560, transcript variant X2
uncharacterized protein LOC110387560 isoform X1
uncharacterized protein LOC110387560 isoform X2
uncharacterized LOC110387560, transcript variant X4
uncharacterized LOC110387560, transcript variant X3
cytotoxic and regulatory T-cell molecule
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin associated and SH3 domain containing B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ubiquitin-associated and SH3 domain-containing protein B
uncharacterized LOC110387542, transcript variant X14
uncharacterized LOC110387542, transcript variant X1
uncharacterized LOC110387542, transcript variant X21
uncharacterized LOC110387542, transcript variant X23
uncharacterized LOC110387542, transcript variant X26
uncharacterized LOC110387542, transcript variant X30
uncharacterized LOC110387542, transcript variant X19
uncharacterized LOC110387542, transcript variant X22
uncharacterized LOC110387542, transcript variant X12
uncharacterized LOC110387542, transcript variant X25
uncharacterized LOC110387542, transcript variant X16
uncharacterized LOC110387542, transcript variant X10
uncharacterized LOC110387542, transcript variant X11
uncharacterized LOC110387542, transcript variant X4
uncharacterized LOC110387542, transcript variant X7
uncharacterized LOC110387542, transcript variant X18
uncharacterized LOC110387542, transcript variant X20
uncharacterized LOC110387542, transcript variant X5
uncharacterized LOC110387542, transcript variant X6
uncharacterized LOC110387542, transcript variant X8
uncharacterized LOC110387542, transcript variant X17
uncharacterized LOC110387542, transcript variant X34
uncharacterized LOC110387542, transcript variant X32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC110387542, transcript variant X27
uncharacterized LOC110387542, transcript variant X2
uncharacterized LOC110387542, transcript variant X3
uncharacterized LOC110387542, transcript variant X33
uncharacterized LOC110387542, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC110387542, transcript variant X15
uncharacterized LOC110387542, transcript variant X13
uncharacterized LOC110387542, transcript variant X9
uncharacterized LOC110387542, transcript variant X29
uncharacterized LOC110387542, transcript variant X31
uncharacterized LOC110387542, transcript variant X28
sortilin related receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
sortilin related receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tubulin folding cofactor E like, transcript variant X2
tubulin folding cofactor E like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
tubulin folding cofactor E like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tubulin-specific chaperone cofactor E-like protein isoform X1
tubulin-specific chaperone cofactor E-like protein isoform X2
glutamate ionotropic receptor kainate type subunit 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 4
glutamate ionotropic receptor kainate type subunit 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 12, transcript variant X2
Rho guanine nucleotide exchange factor 12, transcript variant X1
rho guanine nucleotide exchange factor 12 isoform X2
rho guanine nucleotide exchange factor 12 isoform X1
transmembrane protein 136-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
transmembrane protein 136-like, transcript variant X3
transmembrane protein 136-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transmembrane protein 136-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transmembrane protein 136-like isoform X1
transmembrane protein 136-like isoform X2
transmembrane protein 136-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
POU class 2 homeobox 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
POU class 2 homeobox 3, transcript variant X2
POU class 2 homeobox 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
POU domain, class 2, transcription factor 3 isoform X3
POU domain, class 2, transcription factor 3 isoform X2
POU domain, class 2, transcription factor 3 isoform X1
out at first homolog, transcript variant X2
out at first homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
out at first homolog, transcript variant X1
tripartite motif containing 29, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
tripartite motif containing 29, transcript variant X1
tripartite motif-containing protein 29 isoform X2
tripartite motif-containing protein 29 isoform X1
nectin cell adhesion molecule 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC110387554, transcript variant X3
uncharacterized LOC110387554, transcript variant X1
uncharacterized LOC110387554, transcript variant X4
uncharacterized LOC110387554, transcript variant X2
ubiquitin specific peptidase 2, transcript variant X5
ubiquitin specific peptidase 2, transcript variant X1
ubiquitin specific peptidase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin specific peptidase 2, transcript variant X3
ubiquitin specific peptidase 2, transcript variant X2
ubiquitin specific peptidase 2, transcript variant X6
ubiquitin specific peptidase 2, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 2 isoform X1
ubiquitin carboxyl-terminal hydrolase 2 isoform X2
ubiquitin specific peptidase 2, transcript variant X8
ubiquitin carboxyl-terminal hydrolase 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
C1q and TNF related 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
C1q and TNF related 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
C1q and TNF related 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
C1q and TNF related 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
C1q and TNF related 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
melanoma cell adhesion molecule, transcript variant X1
similar to RNA sequence (same species):INSD:GBYG01022511.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 83 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
melanoma cell adhesion molecule, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 83 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 80 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
cell surface glycoprotein MUC18 isoform X1
cell surface glycoprotein MUC18 isoform X2
Cbl proto-oncogene, transcript variant X1
Cbl proto-oncogene, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
E3 ubiquitin-protein ligase CBL isoform X1
E3 ubiquitin-protein ligase CBL isoform X2
coiled-coil domain containing 153, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
coiled-coil domain containing 153, transcript variant X4
coiled-coil domain containing 153, transcript variant X2
coiled-coil domain-containing protein 153 isoform X4
coiled-coil domain-containing protein 153 isoform X2
coiled-coil domain-containing protein 153 isoform X3
coiled-coil domain containing 153, transcript variant X1
coiled-coil domain containing 153, transcript variant X5
coiled-coil domain-containing protein 153 isoform X5
coiled-coil domain-containing protein 153 isoform X1
PDZ domain containing 3, transcript variant X1
PDZ domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
PDZ domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X3
NLR family member X1, transcript variant X4
NLR family member X1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
NLR family member X1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
NLR family member X1, transcript variant X5
NLR family member X1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP binding cassette subfamily G member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP binding cassette subfamily G member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP binding cassette subfamily G member 4, transcript variant X3
ATP-binding cassette sub-family G member 4
histone H4 transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X2
histone H4 transcription factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X6
colorectal cancer associated 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
colorectal cancer-associated protein 2 isoform X2
colorectal cancer associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
colorectal cancer-associated protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
colorectal cancer associated 2, transcript variant X3
POU class 2 associating factor 1, transcript variant X1
POU domain class 2-associating factor 1 isoform X1
POU class 2 associating factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
POU class 2 associating factor 1, transcript variant X3
POU class 2 associating factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
POU domain class 2-associating factor 1 isoform X3
POU domain class 2-associating factor 1 isoform X2
POU domain class 2-associating factor 1 isoform X4
lysine methyltransferase 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
lysine methyltransferase 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
lysine methyltransferase 2A, transcript variant X4
lysine methyltransferase 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
histone-lysine N-methyltransferase 2A isoform X4
histone-lysine N-methyltransferase 2A isoform X3
histone-lysine N-methyltransferase 2A isoform X2
histone-lysine N-methyltransferase 2A isoform X1
ATP synthase, H+ transporting, mitochondrial Fo complex subunit G
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
G protein-activated inward rectifier potassium channel 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GBYG01040769.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 79 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 51 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
ubiquitin carboxyl-terminal hydrolase 28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 16, transcript variant X2
zinc finger and BTB domain-containing protein 16 isoform X1
zinc finger and BTB domain-containing protein 16 isoform X2
zinc finger and BTB domain-containing protein 16-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 16-like, transcript variant X1
zinc finger and BTB domain-containing protein 16-like isoform X1
zinc finger and BTB domain-containing protein 16-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 16-like isoform X2
uncharacterized LOC110387675, transcript variant X1
uncharacterized LOC110387675, transcript variant X2
cell adhesion molecule 1, transcript variant X2
cell adhesion molecule 1, transcript variant X1
cell adhesion molecule 1, transcript variant X7
cell adhesion molecule 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cell adhesion molecule 1, transcript variant X3
cell adhesion molecule 1, transcript variant X8
cell adhesion molecule 1, transcript variant X6
cell adhesion molecule 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
apolipoprotein A5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
apolipoprotein A5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
apolipoprotein C-III-like, transcript variant X2
apolipoprotein C-III-like, transcript variant X1
SIK family kinase 3, transcript variant X4
SIK family kinase 3, transcript variant X2
SIK family kinase 3, transcript variant X3
SIK family kinase 3, transcript variant X1
serine/threonine-protein kinase SIK3 isoform X4
serine/threonine-protein kinase SIK3 isoform X2
serine/threonine-protein kinase SIK3 isoform X3
serine/threonine-protein kinase SIK3 isoform X1
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X1
platelet-activating factor acetylhydrolase IB subunit beta isoform X1
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
platelet-activating factor acetylhydrolase IB subunit beta isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SID1 transmembrane family member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 7 isoform X1
proprotein convertase subtilisin/kexin type 7 isoform X2
ring finger protein 214, transcript variant X3
ring finger protein 214, transcript variant X4
ring finger protein 214, transcript variant X1
ring finger protein 214, transcript variant X2
ring finger protein 214, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
centrosomal protein 164, transcript variant X1
centrosomal protein 164, transcript variant X6
centrosomal protein 164, transcript variant X3
centrosomal protein 164, transcript variant X2
centrosomal protein 164, transcript variant X8
centrosomal protein 164, transcript variant X9
centrosomal protein 164, transcript variant X4
centrosomal protein 164, transcript variant X5
centrosomal protein 164, transcript variant X10
centrosomal protein 164, transcript variant X11
centrosomal protein 164, transcript variant X7
centrosomal protein 164, transcript variant X12
centrosomal protein 164, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
centrosomal protein of 164 kDa isoform X1
centrosomal protein of 164 kDa isoform X6
centrosomal protein of 164 kDa isoform X3
centrosomal protein of 164 kDa isoform X2
centrosomal protein of 164 kDa isoform X8
centrosomal protein of 164 kDa isoform X9
centrosomal protein of 164 kDa isoform X4
centrosomal protein of 164 kDa isoform X5
centrosomal protein of 164 kDa isoform X10
centrosomal protein of 164 kDa isoform X11
centrosomal protein of 164 kDa isoform X7
centrosomal protein of 164 kDa isoform X13
centrosomal protein of 164 kDa isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Down syndrome cell adhesion molecule-like protein 1
FXYD domain containing ion transport regulator 2, transcript variant X2
FXYD domain containing ion transport regulator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit gamma isoform X2
sodium/potassium-transporting ATPase subunit gamma isoform X1
FXYD domain-containing ion transport regulator 6-like, transcript variant X1
FXYD domain-containing ion transport regulator 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC110387601 isoform X1
FXYD domain-containing ion transport regulator 6-like isoform X2
uncharacterized LOC110387611, transcript variant X2
uncharacterized LOC110387611, transcript variant X1
transmembrane protease, serine 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
transmembrane protease, serine 13, transcript variant X2
transmembrane protease, serine 13, transcript variant X3
transmembrane protease, serine 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transmembrane protease, serine 13, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transmembrane protease serine 13 isoform X4
transmembrane protease serine 13 isoform X2
transmembrane protease serine 13 isoform X3
transmembrane protease serine 13 isoform X1
transmembrane protease serine 13 isoform X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: interleukin-10 receptor subunit alpha
uncharacterized LOC110387609, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC110387609, transcript variant X9
uncharacterized LOC110387609, transcript variant X7
uncharacterized LOC110387609, transcript variant X6
uncharacterized LOC110387609, transcript variant X5
uncharacterized LOC110387609, transcript variant X3
uncharacterized LOC110387609, transcript variant X1
uncharacterized LOC110387609, transcript variant X4
uncharacterized LOC110387609, transcript variant X2
transmembrane protease, serine 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transmembrane protease, serine 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transmembrane protease serine 4 isoform X1
transmembrane protease serine 4 isoform X2
transmembrane protease, serine 4, transcript variant X3
transmembrane protease serine 4 isoform X3
sodium voltage-gated channel beta subunit 4, transcript variant X2
sodium voltage-gated channel beta subunit 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
sodium voltage-gated channel beta subunit 4, transcript variant X3
sodium channel subunit beta-4 isoform X2
sodium channel subunit beta-4 isoform X1
sodium channel subunit beta-4 isoform X3
sodium voltage-gated channel beta subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
junctional adhesion molecule-like, transcript variant X6
junctional adhesion molecule-like, transcript variant X2
junctional adhesion molecule-like, transcript variant X4
junctional adhesion molecule-like, transcript variant X3
junctional adhesion molecule-like, transcript variant X5
junctional adhesion molecule-like, transcript variant X1
junctional adhesion molecule-like isoform X2
junctional adhesion molecule-like isoform X1
myelin protein zero like 2, transcript variant X2
myelin protein zero like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
myelin protein zero-like protein 2 isoform X2
myelin protein zero-like protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
T-cell surface glycoprotein CD3 epsilon chain
T-cell surface glycoprotein CD3 gamma chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
centromere/kinetochore protein zw10 homolog
transmembrane protease, serine 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protease, serine 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protease, serine 5, transcript variant X2
transmembrane protease, serine 5, transcript variant X1
transmembrane protease, serine 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protease, serine 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protease serine 5 isoform X4
transmembrane protease serine 5 isoform X2
transmembrane protease serine 5 isoform X1
transmembrane protease serine 5 isoform X6
transmembrane protease serine 5 isoform X7
transmembrane protease serine 5 isoform X3
transmembrane protease, serine 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protease serine 5 isoform X5
intraflagellar transport 46, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
intraflagellar transport 46, transcript variant X1
intraflagellar transport protein 46 homolog isoform X1
intraflagellar transport protein 46 homolog isoform X2
NF-kappa-B inhibitor zeta-like, transcript variant X1
NF-kappa-B inhibitor zeta-like, transcript variant X2
NF-kappa-B inhibitor zeta-like isoform X2
NF-kappa-B inhibitor zeta-like isoform X1
uncharacterized LOC110387733, transcript variant X4
uncharacterized LOC110387733, transcript variant X1
uncharacterized LOC110387733, transcript variant X5
uncharacterized LOC110387733, transcript variant X2
uncharacterized protein LOC110387733 isoform X1
uncharacterized protein LOC110387733 isoform X3
uncharacterized LOC110387733, transcript variant X3
uncharacterized protein LOC110387733 isoform X2
BTG anti-proliferation factor 4, transcript variant X2
BTG anti-proliferation factor 4, transcript variant X1
chromosome 23 C11orf88 homolog, transcript variant X7
chromosome 23 C11orf88 homolog, transcript variant X5
chromosome 23 C11orf88 homolog, transcript variant X2
chromosome 23 C11orf88 homolog, transcript variant X1
chromosome 23 C11orf88 homolog, transcript variant X6
chromosome 23 C11orf88 homolog, transcript variant X4
chromosome 23 C11orf88 homolog, transcript variant X3
UPF0722 protein C11orf88 homolog isoform X1
UPF0722 protein C11orf88 homolog isoform X5
UPF0722 protein C11orf88 homolog isoform X2
UPF0722 protein C11orf88 homolog isoform X4
UPF0722 protein C11orf88 homolog isoform X3
UPF0722 protein C11orf88 homolog isoform X6
chromosome 23 C11orf88 homolog, transcript variant X8
DEAD-box helicase 6, transcript variant X1
DEAD-box helicase 6, transcript variant X2
probable ATP-dependent RNA helicase DDX6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
B-cell CLL/lymphoma 9 like, transcript variant X2
B-cell CLL/lymphoma 9 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
B-cell CLL/lymphoma 9-like protein isoform X1
B-cell CLL/lymphoma 9-like protein isoform X2
coiled-coil domain containing 84, transcript variant X5
coiled-coil domain containing 84, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
coiled-coil domain containing 84, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
coiled-coil domain containing 84, transcript variant X2
coiled-coil domain containing 84, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
coiled-coil domain-containing protein 84 isoform X1
coiled-coil domain-containing protein 84 isoform X2
trafficking protein particle complex subunit 4
solute carrier family 37 member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 37 member 4, transcript variant X1
glucose-6-phosphate exchanger SLC37A4 isoform X1
glucose-6-phosphate exchanger SLC37A4 isoform X2
pleckstrin homology like domain family B member 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X8
pleckstrin homology like domain family B member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X1
pleckstrin homology like domain family B member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X5
pleckstrin homology like domain family B member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X11
pleckstrin homology-like domain family B member 1 isoform X6
pleckstrin homology like domain family B member 1, transcript variant X3
pleckstrin homology like domain family B member 1, transcript variant X10
pleckstrin homology-like domain family B member 1 isoform X2
pleckstrin homology-like domain family B member 1 isoform X9
pleckstrin homology-like domain family B member 1 isoform X4
pleckstrin homology-like domain family B member 1 isoform X10
pleckstrin homology-like domain family B member 1 isoform X7
pleckstrin homology-like domain family B member 1 isoform X5
pleckstrin homology-like domain family B member 1 isoform X3
pleckstrin homology-like domain family B member 1 isoform X1
pleckstrin homology-like domain family B member 1 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and kinase domain containing 1
ankyrin repeat and protein kinase domain-containing protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
LOW QUALITY PROTEIN: tetratricopeptide repeat protein 12
neural cell adhesion molecule 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neural cell adhesion molecule 1, transcript variant X1
neural cell adhesion molecule 1, transcript variant X3
neural cell adhesion molecule 1 isoform X1
neural cell adhesion molecule 1 isoform X3
neural cell adhesion molecule 1 isoform X2
neural cell adhesion molecule 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
neural cell adhesion molecule 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
neural cell adhesion molecule 1 isoform X5
neural cell adhesion molecule 1 isoform X4
6-pyruvoyltetrahydropterin synthase, transcript variant X4
6-pyruvoyltetrahydropterin synthase, transcript variant X2
6-pyruvoyltetrahydropterin synthase, transcript variant X3
6-pyruvoyltetrahydropterin synthase, transcript variant X1
6-pyruvoyl tetrahydrobiopterin synthase isoform X2
6-pyruvoyl tetrahydrobiopterin synthase isoform X1
6-pyruvoyl tetrahydrobiopterin synthase isoform X4
6-pyruvoyl tetrahydrobiopterin synthase isoform X3
beta-carotene oxygenase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
beta-carotene oxygenase 2, transcript variant X7
beta-carotene oxygenase 2, transcript variant X5
beta-carotene oxygenase 2, transcript variant X8
beta-carotene oxygenase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
beta-carotene oxygenase 2, transcript variant X3
beta-carotene oxygenase 2, transcript variant X2
beta-carotene oxygenase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
beta,beta-carotene 9',10'-oxygenase isoform X3
beta,beta-carotene 9',10'-oxygenase isoform X2
beta,beta-carotene 9',10'-oxygenase isoform X1
beta,beta-carotene 9',10'-oxygenase isoform X4
beta,beta-carotene 9',10'-oxygenase isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
succinate dehydrogenase complex subunit D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized protein C11orf57 homolog
PIH1 domain containing 2, transcript variant X1
PIH1 domain containing 2, transcript variant X2
PIH1 domain-containing protein 2 isoform X1
PIH1 domain-containing protein 2 isoform X2
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial
DIX domain containing 1, transcript variant X4
DIX domain containing 1, transcript variant X5
DIX domain containing 1, transcript variant X3
DIX domain containing 1, transcript variant X6
DIX domain containing 1, transcript variant X7
DIX domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
DIX domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein C11orf52 homolog
crystallin alpha B, transcript variant X2
crystallin alpha B, transcript variant X3
heat shock protein family B (small) member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
crystallin alpha B, transcript variant X1
ferredoxin-fold anticodon binding domain containing 1, transcript variant X2
ferredoxin-fold anticodon binding domain containing 1, transcript variant X1
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X1
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X2
ALG9, alpha-1,2-mannosyltransferase, transcript variant X1
ALG9, alpha-1,2-mannosyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ALG9, alpha-1,2-mannosyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ALG9, alpha-1,2-mannosyltransferase, transcript variant X5
ALG9, alpha-1,2-mannosyltransferase, transcript variant X4
alpha-1,2-mannosyltransferase ALG9 isoform X1
alpha-1,2-mannosyltransferase ALG9 isoform X2
alpha-1,2-mannosyltransferase ALG9 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
von Willebrand factor A domain-containing protein 5A-like, transcript variant X2
von Willebrand factor A domain-containing protein 5A-like, transcript variant X3
von Willebrand factor A domain-containing protein 5A-like, transcript variant X1
von Willebrand factor A domain-containing protein 5A-like isoform X2
von Willebrand factor A domain-containing protein 5A-like isoform X3
von Willebrand factor A domain-containing protein 5A-like isoform X1
von Willebrand factor A domain-containing protein 5A-like, transcript variant X4
von Willebrand factor A domain-containing protein 5A-like isoform X4